Supported by $5.4 million from the Victoria State Government via mRNA Victoria, the Victorian mRNA Innovation Hub is headquartered at Monash Institute of Pharmaceutical Sciences at Monash University in Melbourne, Australia. The VMIH is collaboration between the Monash Institute of Pharmaceutical Sciences, the Monash Biomedicine Discovery Institute, the University of Melbourne and the Peter Doherty Institute for Infection and Immunity, working towards advancing innovative next-generation RNA therapeutic designs and delivery systems, aiming to improve the treatment and prevention a range of diseases.